The purpose of this conference was to educate and update attendees with the most clinically relevant information with an emphasis on recent advances in electrophysiology, heart failure, interventional cardiology, and structural heart disease. This comprehensive program includes interactive discussions and case presentations offered by experts in the field and provided an opportunity for health professionals in the Mid-Atlantic region to network and exchange ideas on patient management and clinical practice.
Sentara Healthcare’s 2022 Heart of Innovation: Concepts in Cardiology targeted physicians and allied health professionals from the across the state of Virginia and the Mid-Atlantic region. This one-day conference provided expert insight into key areas of cardiology with a balanced perspective on guidelines and patient management. World class faculty offered insights on the latest topics in cardiology and was organized into two tracks so there was something for everyone.
Sentara Master Series |view more
Sentara Master Series Presents a LIVE MitraClip Mitral Valve Repair
Dr. Matthew Summers and Dr. David Adler performed a LIVE MitraClip procedure, with Dr. Deepak Talreja serving as Moderator. The team discussed how the procedure is performed, which patients are best candidates, and recovery time involved.
Sentara Master Series Presents: A LIVE WATCHMAN Procedure
Join Venkat Iyer, M.D., Electrophysiologist at Sentara Health, as he performs a WATCHMAN procedure and describes the step-by-step process as he guides the left atrial appendage closure device into the heart.
Sentara Master Series Presents a Live CardioMEMS™ Implant Performed by Deepak Talreja, M.D.
The CardioMEMS™ sensor is implanted in the pulmonary artery during a minimally invasive catheterization procedure. The placement of this device allows heart failure patients to take a daily pressure reading to monitor fluid buildup.
Transcatheter Aortic Valve Replacement (TAVR)
TAVR is a minimally invasive cardiac procedure for patients with aortic valve stenosis at low, intermediate or high risk for standard valve replacement surgery.